Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

NET 3Endocrine 3

Conditions

Neoplasms 15Papillomavirus Infections 9Uterine Cervical Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 5Breast Neoplasms 5Prostatic Neoplasms 4Neuroendocrine Tumors 3Neoplasm Metastasis 3Myasthenia Gravis 3Multiple Myeloma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Autoimmune Diseases 3Thyroid Diseases 2Pancreatic Cyst 2Neuroblastoma 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Leukemia 2Hematologic Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Abortion, Spontaneous 2

Interventions

lutetium Lu 177 dotatate 5Data Collection 3telotristat ethyl 2Somatostatin 2Positron-Emission Tomography 2Magnetic Resonance Spectroscopy 2Everolimus 2Drug Therapy 2Biopsy 2surufatinib 1lanreotide 1copper dotatate CU-64 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorafenib 1Salvage Therapy 1Radionuclide Imaging 1Radiomics 1Radiofrequency Ablation 1Quality of Life 1Plastic Surgery Procedures 1Phlebotomy 1Patient Reported Outcome Measures 1Octreotide 1Molecular Diagnostic Techniques 1Lutetium-177 1Lutetium 1Liver Transplantation 1Laparoscopy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Neuroendocrine Tumors × Data Collection × Clear all
NCT03562091 2020-08-28

OPERA

Ipsen

Completed
115 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03112694 2020-06-02

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Ipsen

Completed
93 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03220087 2018-12-21

RECOSY

Ipsen

Completed
142 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡